Hyperglucagonemia and insulin-mediated glucose metabolism.

The effect of chronic physiologic hyperglucagonemia on basal and insulin-mediated glucose metabolism was evaluated in normal subjects, using the euglycemic insulin clamp technique (+50, +100, and +500 microU/ml). After glucagon infusion fasting glucose increased from 76 +/- 4 to 93 +/- 2 mg/dl and hepatic glucose production (HGP) rose from 1.96 +/- 0.08 to 2.25 +/- 0.08 mg/kg X min (P less than 0.001). Basal glucose oxidation after glucagon increased (P less than 0.05) and correlated inversely with decreased free fatty acid concentrations (r = -0.94; P less than 0.01) and decreased lipid oxidation (r = -0.75; P less than 0.01). Suppression of HGP and stimulation of total glucose disposal were impaired at each insulin step after glucagon (P less than 0.05-0.01). The reduction in insulin-mediated glucose uptake was entirely due to diminished non-oxidative glucose utilization. Glucagon infusion also caused a decrease in basal lipid oxidation and an enhanced ability of insulin to inhibit lipid oxidation and augment lipid synthesis. These results suggest that hyperglucagonemia may contribute to the disturbances in glucose and lipid metabolism in some diabetic patients.

[1]  D. Rapport,et al.  ANIMAL CALORIMETRY Twenty-Eighth Paper. THE RESPIRATORY METABOLISM OF A YOUNG PIG AS INFLUENCED BY FOOD AND BENZOIC ACID , 1924 .

[2]  J. I. Goodman.  Hepatomegaly and diabetes mellitus. , 1953, Annals of internal medicine.

[3]  R. Steele,et al.  INFLUENCES OF GLUCOSE LOADING AND OF INJECTED INSULIN ON HEPATIC GLUCOSE OUTPUT * , 1959, Annals of the New York Academy of Sciences.

[4]  E. Newsholme,et al.  The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. , 1963, Lancet.

[5]  G. W. Snedecor.  Statistical Methods , 1964 .

[6]  V. Herbert,et al.  Coated charcoal immunoassay of insulin. , 1965, The Journal of clinical endocrinology and metabolism.

[7]  M. Novak.  COLORIMETRIC ULTRAMICRO METHOD FOR THE DETERMINATION OF FREE FATTY ACIDS. , 1965, Journal of lipid research.

[8]  P. Foà,et al.  Effect of Glucagon and of Insulin on Serum Free Fatty Acids in Normal and Depancreatized Dogs∗ , 1969, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[9]  G. Hetényi,et al.  Glucoregulatory responses in normal and diabetic dogs recorded by a new tracer method. , 1971, Metabolism: clinical and experimental.

[10]  E. Jéquier,et al.  Carbohydrate and lipid oxidation in normal human subjects: its influence on glucose tolerance and insulin response to glucose. , 1972, Metabolism: clinical and experimental.

[11]  M. Vranic,et al.  Effect of interaction between insulin and glucagon on glucose turnover and FFA concentration in normal and depancreatized dogs. , 1974, Metabolism: clinical and experimental.

[12]  R. Guillemin,et al.  Effects of somatostatin on plasma glucose and glucagon levels in human diabetes mellitus. Pathophysiologic and therapeutic implications. , 1974, The New England journal of medicine.

[13]  L. Orci,et al.  THE ESSENTIAL ROLE OF GLUCAGON IN THE PATHOGENESIS OF DIABETES MELLITUS , 1975, The Lancet.

[14]  J. McGarry,et al.  Hormonal control of ketogenesis. Rapid activation of hepatic ketogenic capacity in fed rats by anti-insulin serum and glucagon. , 1975, The Journal of clinical investigation.

[15]  G. Reaven,et al.  Demonstration of insulin resistance in untreated adult onset diabetic subjects with fasting hyperglycemia. , 1975, The Journal of clinical investigation.

[16]  E. Tsalikian,et al.  Prevention of human diabetic ketoacidosis by somatostatin. Evidence for an essential role of glucagon. , 1975, The New England journal of medicine.

[17]  G. Reaven,et al.  Nonketotic diabetes mellitus: insulin deficiency or insulin resistance? , 1976, The American journal of medicine.

[18]  R. Moxley,et al.  Metabolism of Forearm Tissues in Man: Studies with Glucagon , 1976, Diabetes.

[19]  P. Felig,et al.  Influence of physiologic hyperglucagonemia on basal and insulin-inhibited splanchnic glucose output in normal man. , 1976, The Journal of clinical investigation.

[20]  J. Chiasson,et al.  Differential Sensitivity of Glycogenolysis and Gluconeogenesis to Insulin Infusions in Dogs , 1976, Diabetes.

[21]  S. B. Lewis,et al.  Transient Stimulatory Effect of Sustained Hyperglucagonemia on Splanchnic Glucose Production in Normal and Diabetic Man , 1977, Diabetes.

[22]  J. Gerich.  On the Causes and Consequences of Abnormal Glucagon Secretion in Human Diabetes Mellitus , 1977 .

[23]  Ginsberg Hn.  Investigation of insulin sensitivity in treated subjects with ketosis-prone diabetes mellitus. , 1977 .

[24]  L. Sjöström,et al.  Carbohydrate storage in man: speculations and some quantitative considerations. , 1978, Metabolism: clinical and experimental.

[25]  R. Sherwin,et al.  Hyperglycemia inhibits glucose production in man independent of changes in glucoregulatory hormones. , 1978, The Journal of clinical endocrinology and metabolism.

[26]  C. Kahn.  Insulin resistance, insulin insensitivity, and insulin unresponsiveness: a necessary distinction. , 1978, Metabolism: clinical and experimental.

[27]  R. DeFronzo,et al.  Influence of hyperinsulinemia, hyperglycemia, and the route of glucose administration on splanchnic glucose exchange. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[28]  O. Owen,et al.  Effects of Chronic Glucagon Excess on Hepatic Metabolism , 1978, Diabetes.

[29]  R. DeFronzo,et al.  Insulin binding to monocytes and insulin action in human obesity, starvation, and refeeding. , 1978, The Journal of clinical investigation.

[30]  R. DeFronzo,et al.  Insulin sensitivity and insulin binding to monocytes in maturity-onset diabetes. , 1979, The Journal of clinical investigation.

[31]  R. Rizza,et al.  Persistent effect of sustained hyperglucagonemia on glucose production in man. , 1979, The Journal of clinical endocrinology and metabolism.

[32]  R. Rizza,et al.  Effect of intermittent endogenous hyperglucagonemia on glucose homeostasis in normal and diabetic man. , 1979, The Journal of clinical investigation.

[33]  R. DeFronzo,et al.  Epinephrine-induced insulin resistance in man. , 1980, The Journal of clinical investigation.

[34]  G. Shulman,et al.  Effect of hyperglycemia independent of changes in insulin or glucagon on lipolysis in the conscious dog. , 1980, Metabolism: clinical and experimental.

[35]  J. Olefsky,et al.  Mechanisms of insulin resistance in obesity and noninsulin-dependent (type II) diabetes. , 1981, The American journal of medicine.

[36]  G. Shulman,et al.  Differential Time Course of Glucagon's Effect on Glycogenolysis and Gluconeogenesis in the Conscious Dog , 1981, Diabetes.

[37]  L. Mandarino,et al.  Mechanism and Significance of Insulin Resistance in Non-insulin-dependent Diabetes Mellitus , 1981, Diabetes.

[38]  R. DeFronzo,et al.  The Effect of Insulin on the Disposal of Intravenous Glucose: Results from Indirect Calorimetry and Hepatic and Femoral Venous Catheterization , 1981, Diabetes.

[39]  A. Cherrington,et al.  The Relative Importance of First- and Second-Phase Insulin Secretion in Countering the Action of Glucagon on Glucose Turnover in the Conscious Dog , 1982, Diabetes.

[40]  R. DeFronzo,et al.  Transient hepatic response to glucagon in man: role of insulin and hyperglycemia. , 1982, The American journal of physiology.

[41]  C. Cobelli,et al.  Insulin sensitivity, binding, and kinetics in pancreatogenic and type I diabetes. , 1982, Diabetes.

[42]  R. DeFronzo,et al.  Effect of long chain triglyceride infusion on glucose metabolism in man. , 1982, Metabolism: clinical and experimental.

[43]  R. DeFronzo,et al.  The effect of growth hormone on glucose metabolism and insulin secretion in man. , 1982, The Journal of clinical endocrinology and metabolism.

[44]  R. DeFronzo,et al.  Insulin Resistance is a Prominent Feature of Insulin-dependent Diabetes , 1982, Diabetes.

[45]  C. Newgard,et al.  Studies on the mechanism by which exogenous glucose is converted into liver glycogen in the rat. A direct or an indirect pathway? , 1983, The Journal of biological chemistry.

[46]  R. DeFronzo,et al.  New concepts in the pathogenesis and treatment of noninsulin-dependent diabetes mellitus. , 1983, The American journal of medicine.

[47]  R. DeFronzo,et al.  Effect of fatty acids on glucose production and utilization in man. , 1983, The Journal of clinical investigation.

[48]  M. Muggeo,et al.  Effects of chronic glucocorticoid excess in man on insulin binding to circulating cells: differences between endogenous and exogenous hypercorticism. , 1983, The Journal of clinical endocrinology and metabolism.

[49]  A. Tiengo,et al.  Insulin resistance in Cushing's syndrome. , 1983, The Journal of clinical endocrinology and metabolism.

[50]  K. Frayn,et al.  Calculation of substrate oxidation rates in vivo from gaseous exchange. , 1983, Journal of applied physiology: respiratory, environmental and exercise physiology.

[51]  R. DeFronzo,et al.  Regulation of Splanchnic and Peripheral Glucose Uptake by Insulin and Hyperglycemia in Man , 1983, Diabetes.

[52]  P. Gruppuso,et al.  Chronic hyperglucagonemia in rats: effects on insulin, substrates, and hepatic enzymes of intermediary metabolism. , 1983, Metabolism: clinical and experimental.

[53]  M. Vranic,et al.  Minimal Increases in Glucagon Levels Enhance Glucose Production in Man with Partial Hypoinsulinemia , 1983, Diabetes.

[54]  P. Lefèbvre.  Glucagon and Adipose Tissue Lipolysis , 1983 .

[55]  C. Cobelli,et al.  Insulin-mediated glucose disposal in type I diabetes: evidence for insulin resistance. , 1983, Journal of Clinical Endocrinology and Metabolism.

[56]  G. Weir,et al.  Increased Insulin Responsiveness In Vivo and In Vitro Consequent to Induced Hyperinsulinemia in the Rat , 1984, Diabetes.

[57]  H. Yki-Järvinen,et al.  Insulin sensitivity in newly diagnosed type 1 diabetics after ketoacidosis and after three months of insulin therapy. , 1984, The Journal of clinical endocrinology and metabolism.

[58]  A. Kashiwagi,et al.  Insulin sensitivity in pancreatitis, liver diseases, steroid treatment and hyperthyroidism assessed by glucose, insulin and somatostatin infusion. , 1984, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[59]  J. Halter,et al.  Prolonged infusion of somatostatin with glucagon replacement increases plasma glucose and glucose turnover in man. , 1984, The Journal of clinical endocrinology and metabolism.

[60]  M. Taskinen,et al.  Site of insulin resistance in type 1 diabetes: insulin-mediated glucose disposal in vivo in relation to insulin binding and action in adipocytes in vitro. , 1984, The Journal of clinical endocrinology and metabolism.

[61]  E. Ravussin,et al.  Nutritional influences on lipogenesis and thermogenesis after a carbohydrate meal. , 1984, The American journal of physiology.

[62]  E. Horton,et al.  Regulation of glucose utilization in adipose cells and muscle after long-term experimental hyperinsulinemia in rats. , 1985, The Journal of clinical investigation.